Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - London Finance & Investment Group PLC (LSE:LFI, JSE:LNFI), also known as Lonfin, has received sanction from the High Court of England & Wales for its previously announced share capital reduction. The decision follows the approval by shareholders at a general meeting held on March 28, 2025, where they voted in favor of canceling and extinguishing 30,287,479 ordinary shares in a move to reduce the company’s share capital, known as the "Capital Reduction."
The court order confirming the Capital Reduction, along with a statement of capital, will be submitted to the Registrar of Companies. The Capital Reduction is set to take effect upon the registration of these documents. Additionally, a distribution of £0.7153 per share was approved for shareholders registered at the relevant record dates.
However, due to current delays at Companies House in the United Kingdom (TADAWUL:4280), the implementation of the Capital Reduction will be postponed. The company will notify shareholders of the revised effective date, the currency conversion rate, and the significant dates for the Return of Capital, the withdrawal of the company’s shares from trading on the London Stock Exchange (LON:LSEG), and the termination of its Johannesburg Stock Exchange listing. These updates will be communicated through a Regulatory Information Service (RIS) and on the Stock Exchange News Service (SENS).
The announcement made today is based on a press release statement from the company. The independent directors of Lonfin have taken responsibility for the contents of this announcement. Shareholders and interested parties are advised to stay tuned for further announcements regarding the Capital Reduction and its implications for the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.